<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Neuromuscular Diseases</journal-id><journal-title-group><journal-title xml:lang="en">Neuromuscular Diseases</journal-title><trans-title-group xml:lang="ru"><trans-title>Нервно-мышечные болезни</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2222-8721</issn><issn publication-format="electronic">2413-0443</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">212</article-id><article-id pub-id-type="doi">10.17650/2222-8721-2017-7-3-43-46</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL REPORTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Sleep disorders of insomnia type in patients with amyotrophic lateral sclerosis</article-title><trans-title-group xml:lang="ru"><trans-title>Расстройства сна инсомнического характера у больных боковым амиотрофическим склерозом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Levitskiy</surname><given-names>G. N.</given-names></name><name xml:lang="ru"><surname>Левицкий</surname><given-names>Г. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>alsrus@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Poluektov</surname><given-names>M. G.</given-names></name><name xml:lang="ru"><surname>Полуэктов</surname><given-names>М. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Neurological Diseases</p></bio><bio xml:lang="ru"><p>кафедра нервных болезней</p></bio><email>alsrus@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Russian Amyotrophic Lateral Sclerosis Charity Foundation</institution></aff><aff><institution xml:lang="ru">Благотворительный фонд помощи больным боковым амиотрофическим склерозом</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Clinical Diagnostic Center “Real Health”</institution></aff><aff><institution xml:lang="ru">ООО Клинико-диагностический центр «Реал Хэлс»</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-11-07" publication-format="electronic"><day>07</day><month>11</month><year>2017</year></pub-date><volume>7</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>43</fpage><lpage>46</lpage><history><date date-type="received" iso-8601-date="2017-11-07"><day>07</day><month>11</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2017-11-07"><day>07</day><month>11</month><year>2017</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, Levitskiy G.N., Poluektov M.G.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, Левицкий Г.Н., Полуэктов М.Г.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">Levitskiy G.N., Poluektov M.G.</copyright-holder><copyright-holder xml:lang="ru">Левицкий Г.Н., Полуэктов М.Г.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://nmb.abvpress.ru/jour/article/view/212">https://nmb.abvpress.ru/jour/article/view/212</self-uri><abstract xml:lang="en"><p>Objective: to evaluate the rate of sleep disorders of insomnia type among patients with amyotrophic lateral sclerosis (ALS) and to study the connection between these disorders and clinical characteristics of the disease. Materials and methods. The study included 101 patients (50 men and 51 women) with confirmed ALS diagnosis; mean age was 58.9 ± 9.6 years. The patient data was evaluated using the ALS Functional Rating Scale Respiratory (ALSFRS-R), Hamilton Depression Rating Scale, and ALS-specific Quality of Life Scale. Results. Sleep disorders were observed in 77 (76.3 %) ALS patients, among whom slow progression was more common (χ2 criterion 3.2; р = 0.048), quality of life was significantly lower (t = –2.043; p = 0.044), and total score per the Hamilton Depression Rating Scale was significantly higher (t = –3.98; р = 0.0001). Patients were divided into 3 groups: The 1st group included patients with primarily motor disorders, the 2nd group included patients with pronounced emotional depressive disorders without severe motor disorders, and the 3rd group included patients with both factors but duration of the disease was longer than in the 2nd group. The rate of postsomniac disorders was significantly higher in the 2nd group than in the 1st group (p = 0.022), and combination of presomniac, intrasomniac, and postsomniac disorders was significantly higher in the 3rd group than in the 1st (р = 0.007). Conclusions. Sleep disorders associated with ALS are accompanied by various complaints (presomniac, intrasomniac, postsomniac, or their combinations) depending on the severity of motor or emotional disorders in these patients.</p><p> </p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>amyotrophic lateral sclerosis</kwd><kwd>sleep disorders of insomnia type</kwd><kwd>quality of life</kwd><kwd>emotional disorders</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>боковой амиотрофический склероз</kwd><kwd>расстройства сна инсомнического характера</kwd><kwd>качество жизни</kwd><kwd>эмоциональные нарушения</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Louveau A., Plog B. A., Antila S. et al. Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J Clin Invest 2017;127(9):3210–19. DOI: 10.1172/ JCI90603. PMID: 28862640.</mixed-citation><mixed-citation xml:lang="ru">Louveau A., Plog B. A., Antila S. et al. Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J Clin Invest 2017;127(9):3210–19. DOI: 10.1172/ JCI90603. PMID: 28862640.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Xie L., Kang H., Xu Q. et al. Sleep drives metabolite clearance from the adult brain. Science 2013;342(6156):373–7. DOI: 10.1126/ science.1241224. PMID: 24136970.</mixed-citation><mixed-citation xml:lang="ru">Xie L., Kang H., Xu Q. et al. Sleep drives metabolite clearance from the adult brain. Science 2013;342(6156):373–7. DOI: 10.1126/ science.1241224. PMID: 24136970.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Radunovic A., Annane D., Jewitt K., Mustfa N. Mechanical ventilation</mixed-citation><mixed-citation xml:lang="ru">Radunovic A., Annane D., Jewitt K., Mustfa N. Mechanical ventilation</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><mixed-citation>for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2009;(4):CD004427. DOI: 10.1002/14651858.CD004427.pub2. PMID: 19821325.</mixed-citation></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">4. Полуэктов М. Г., Левин Я. И., Левицкий Г. Н. и др. Расстройства дыхания</mixed-citation><mixed-citation xml:lang="ru">Полуэктов М. Г., Левин Я. И., Левицкий Г. Н. и др. Расстройства дыхания</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><mixed-citation>во сне при болезни двигательного нейрона. Журнал неврологии и психиатрии им. С. С. Корсакова 2005;105(10):4–9. [Poluektov M. G., Levin Ya. I.,</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Levitskiy G.N. et al. Sleep-related breathing disturbances in motor neuron disease. Zhurnal nevrologii i psikhiatrii im. S. S. Korsakova = S. S. Korsakov Journal of Neurology and Psychiatry 2005;105(10): 4–9. (In Russ.)]. PMID:16281372.</mixed-citation></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">5. Gozal E., Sachleben L. R. Jr, Rane M. J. et al. Mild sustained and intermittent hypoxia induce apoptosis in PC-12 cells via different mechanisms. Am J Physiol Cell Physiol 2005;288(3):535–42. DOI: 10.1152/ajpcell.00270.2004. PMID: 15537711.</mixed-citation><mixed-citation xml:lang="ru">Gozal E., Sachleben L. R. Jr, Rane M. J. et al. Mild sustained and intermittent hypoxia induce apoptosis in PC-12 cells via different mechanisms. Am J Physiol Cell Physiol 2005;288(3):535–42. DOI: 10.1152/ajpcell.00270.2004. PMID: 15537711.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">6. Xu J., Nolan M. T., Heinze K. et al. Symptom frequency, severity, and quality of life among persons with three disease trajectories: cancer, ALS, and CHF. Appl Nurs Res 2015;28(4):311–5. DOI: 10.1016/j.apnr.2015.03.005. PMID: 26608431.</mixed-citation><mixed-citation xml:lang="ru">Xu J., Nolan M. T., Heinze K. et al. Symptom frequency, severity, and quality of life among persons with three disease trajectories: cancer, ALS, and CHF. Appl Nurs Res 2015;28(4):311–5. DOI: 10.1016/j.apnr.2015.03.005. PMID: 26608431.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">7. Ahmed R. M., Newcombe R. E., Piper A. J. et al. Sleep disorders and respiratory function in amyotrophic lateral sclerosis. Sleep Med Rev 2016;26:33–42. DOI: 10.1016/j.smrv.2015.05.007. PMID: 26166297.</mixed-citation><mixed-citation xml:lang="ru">Ahmed R. M., Newcombe R. E., Piper A. J. et al. Sleep disorders and respiratory function in amyotrophic lateral sclerosis. Sleep Med Rev 2016;26:33–42. DOI: 10.1016/j.smrv.2015.05.007. PMID: 26166297.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">8. Brooks B. R., Miller R. G., Swash M. et al. El Escorial revisted: revised criteria</mixed-citation><mixed-citation xml:lang="ru">Brooks B. R., Miller R. G., Swash M. et al. El Escorial revisted: revised criteria</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><mixed-citation>for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1(5):293–9. PMID: 11464847.</mixed-citation></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">9. Cedarbaum J. M., Stambler N., Malta E. et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessment of respiratory function. BDNF ALS Study Group (phase III). J Neurol Sci 1999;169(1–2):13–21. PMID: 10540002.</mixed-citation><mixed-citation xml:lang="ru">Cedarbaum J. M., Stambler N., Malta E. et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessment of respiratory function. BDNF ALS Study Group (phase III). J Neurol Sci 1999;169(1–2):13–21. PMID: 10540002.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">10. Jenkinson C., Fitzpatrick R., Swash M., Levvy G. ALSAQ User Manual. Hogan Print Partnership, Oxford, 2000. 112 p.</mixed-citation><mixed-citation xml:lang="ru">Jenkinson C., Fitzpatrick R., Swash M., Levvy G. ALSAQ User Manual. Hogan Print Partnership, Oxford, 2000. 112 p.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">11. Sim M., Reid D., Pallett J., Gordon E. The Hamilton rating scale. An assessment bases on a dothiepin (“rothiaden”) versus imipramine (“Tofranil”) clinical trial. Int Pharmacopsychiatry 1975;10(3):142–8. PMID:1099046.</mixed-citation><mixed-citation xml:lang="ru">Sim M., Reid D., Pallett J., Gordon E. The Hamilton rating scale. An assessment bases on a dothiepin (“rothiaden”) versus imipramine (“Tofranil”) clinical trial. Int Pharmacopsychiatry 1975;10(3):142–8. PMID:1099046.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">12. Lo Coco D., La Bella V. Fatigue, sleep, and nocturnal complaints in patients with amyotrophic lateral sclerosis. Eur J Neurol 2012;19(5):760–3. DOI: 10.1111/j.1468- 1331.2011.03637.x. PMID: 22233269.</mixed-citation><mixed-citation xml:lang="ru">Lo Coco D., La Bella V. Fatigue, sleep, and nocturnal complaints in patients with amyotrophic lateral sclerosis. Eur J Neurol 2012;19(5):760–3. DOI: 10.1111/j.1468- 1331.2011.03637.x. PMID: 22233269.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">13. Голенков А. В., Полуэктов М. Г. Особенности и нарушения сна в пожилом и старческом возрасте. Клиническая геронтология 2012;(7–8):8–13. [Golenkov A. V., Poluektov M. G. Features and disorders of sleep in elderly and senile patients. Klinicheskaya gerontologiya = Clinical Gerontology 2012;(7–8):8–13. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Голенков А. В., Полуэктов М. Г. Особенности и нарушения сна в пожилом и старческом возрасте. Клиническая геронтология 2012;(7–8):8–13. [Golenkov A. V., Poluektov M. G. Features and disorders of sleep in elderly and senile patients. Klinicheskaya gerontologiya = Clinical Gerontology 2012;(7–8):8–13. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">14. Голенков А. В. Нарушения сна и психическая патология. В кн.: Сомнология и медицина сна: национальное руководство памяти А. М. Вейна</mixed-citation><mixed-citation xml:lang="ru">Голенков А. В. Нарушения сна и психическая патология. В кн.: Сомнология и медицина сна: национальное руководство памяти А. М. Вейна</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><mixed-citation>и Я. И. Левина. Под ред. М. Г. Полуэктова. М.: Медфорум, 2016. C. 508–523. [Golenkov A. V. Sleep disorders and psychiatric pathology. In book: Somnology and medicine of sleep: National guidelines in the memory of A. M. Veyn and</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Ya. I. Levin. Ed. M.G. Poluektov. Moscow: Medforum, 2016. Pp. 508–523. (In Russ.)].</mixed-citation></ref></ref-list></back></article>
